University of Calgary

Ongoing Studies

 PI Title Source Year
 Total Funding
Abstract
 Rabeneck    
Team in Population-Based Colorectal Cancer Screening
 CIHR  2007-2012  $2.4Million  
 McGregor Engaging family physicians in an intervention to increase uptake of colorectal cancer screening  ACB  2007-2010 
 $456,309  
 Hilsden Evaluation of a novel serum-marker of colorectal cancer
 PDI  2008-2010  $100,000  
 Rabeneck  Risk of Advanced Proximal Neoplasia
 CIHR      
 Rostom  A randomized prospective trial comparing oral sodium phosphate, polyethylene glycol-based lavage (Golytely) and split dose polyethylene glycol-based lavage in the preparation of patients undergoing colonoscopy.  Internal      
 Rostom  A randomized prospective trial comparing magnesium citrate (Pico-Salax) alone, Pico-Salax plus bisacody, and oral sodium phosphate in preparation of patients for colonoscopy.  Internal      
 Hilsden  Understanding Canadians' preferences for a colorectal cancer screening program  CIHR  2005 - 2008
 $99,810  
 Hilsden  Societalcosts of colorectal cancer screening in Alberta
 AHFMR  2005 - 2008
 $129,755  

 

CIHR: Canadian Institutes of Health Research
ACB: Alberta Cancer Board 

PDI: Phenomenome Discoveries Inc, Saskatoon, SK

______________________________________________________________________________________ 2008 Forzani & MacPhail Colon Cancer Screening Centre. All rights reserved.
Privacy Policy | Terms of Use | Medical Disclaimer | Disclaimer of Endorsment & Liability